Intelligence / Healthtech / Health Funding Register / Superluminal Medicines, Inc.
Fundingraised $65.5M3 Sept 2026
Superluminal Medicines, Inc.
3 Sept 2026: Raised $65.5M · Boston, MA. Recorded in the SEC Form D data sets.
- Filed
- 3 Sept 2026
- Location
- Boston, MA
- State
- Massachusetts
- Industry
- Biotechnology
- Amount raised
- $65.5M
- Offering size
- $65.5M
- Revenue range
- Decline to Disclose
- Year of incorporation
- 2023
- Entity type
- Corporation
- Jurisdiction
- Delaware
- First sale
- 2026-08-10
- Securities
- Equity
- Investors so far
- 16
- SEC CIK
- 0001989478
What this signal means
Companies buy in the months after they raise: new hires, new vendors, new markets.
- 137 added in the 30 days to 30 Sept 2026.
- 114 of them (29%) raised $5M or more.
Reach them with AOS
Find the decision makers at Superluminal Medicines, Inc.
AOS maps the buying committee, finds verified work emails and drafts outreach that cites this funding signal, for your approval.
Across AOS Research
Other records for Superluminal Medicines, Inc. in our registers.
More from Massachusetts
Health Funding Register
28 SeptXact Bio, Inc.raised $10.0M · Boston, MAFunding25 SeptAutoIVF, Inc.raised $1.5M · Natick, MAFunding25 SeptWay Biosolutions, Inc.raised $2.0M · Cambridge, MAFunding21 SeptFresenius Medical Care Will Clayton, LLCraised $3.8M · Waltham, MAFunding21 SeptTypewriter Therapeutics, Inc.raised $56.3M · Cambridge, MAFunding17 SeptSurgiBox Inc.raised $486K · Cambridge, MAFunding
Source: SEC Form D data sets, data to 30 Sept 2026. New Form D notices filed in Q3 2026 by health and life-sciences companies; pooled investment funds and amendments excluded. Amounts are as reported to the SEC. AOS shows what the public record says; it does not verify or endorse the company.